Abstract
Circulating microRNAs (miRNA) are relatively stable in plasma and are a new class of disease biomarkers. Here we present evidence that high-density lipoprotein (HDL) transports endogenous miRNAs and delivers them to recipient cells with functional targeting capabilities. Cellular export of miRNAs to HDL was demonstrated to be regulated by neutral sphingomyelinase. Reconstituted HDL injected into mice retrieved distinct miRNA profiles from normal and atherogenic models. HDL delivery of both exogenous and endogenous miRNAs resulted in the direct targeting of messenger RNA reporters. Furthermore, HDL-mediated delivery of miRNAs to recipient cells was demonstrated to be dependent on scavenger receptor class B type I. The human HDL–miRNA profile of normal subjects is significantly different from that of familial hypercholesterolemia subjects. Notably, HDL–miRNA from atherosclerotic subjects induced differential gene expression, with significant loss of conserved mRNA targets in cultured hepatocytes. Collectively, these observations indicate that HDL participates in a mechanism of intercellular communication involving the transport and delivery of miRNAs.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Change history
08 December 2014
In the version of this Article originally published online, incorrect values appearing in Supplementary Table S4 were used to generate Fig. 3a and to calculate the P and R values. The annotation between Exosome and HDL should have read ‘R = 0.22*’, the annotation between Exosome and LDL should have read ‘R = 0.63**’ and the annotation between HDL and LDL should have read ‘R = 0.54**’, where **P < 0.0001 and *P < 0.001. These errors have been corrected in the online versions of the Article, and in the Supplementary Information.
23 December 2014
Nat. Cell Biol. 13, 423–433 (2011); published online 20 March 2011; corrected after print 8 December 2014 In the version of this Article originally published online, incorrect values appearing in Supplementary Table S4 were used to generate Fig. 3a and to calculate the P and R values. The annotationbetween Exosome and HDL should have read 'R = 0.
References
Simons, M. & Raposo, G. Exosomes–vesicular carriers for intercellular communication. Curr. Opin. Cell Biol. 21, 575–581 (2009).
Valadi, H. et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9, 654–659 (2007).
Hunter, M. P. et al. Detection of microRNA expression in human peripheral blood microvesicles. PLoS One 3, e3694 (2008).
Ratajczak, J., Wysoczynski, M., Hayek, F., Janowska-Wieczorek, A. & Ratajczak, M. Z. Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia 20, 1487–1495 (2006).
Selbach, M. et al. Widespread changes in protein synthesis induced by microRNAs. Nature 455, 58–63 (2008).
Baek, D. et al. The impact of microRNAs on protein output. Nature 455, 64–71 (2008).
Bartel, D. P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281–297 (2004).
Mitchell, P. S. et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl Acad. Sci. USA 105, 10513–10518 (2008).
Janas, T., Janas, T. & Yarus, M. Specific RNA binding to ordered phospholipid bilayers. Nucleic Acids Res. 34, 2128–2136 (2006).
Manavbasi, Y. & Suleymanoglu, E. Nucleic acid-phospholipid recognition: Fourier transform infrared spectrometric characterization of ternary phospholipid-inorganic cation-DNA complex and its relevance to chemicopharmaceutical design of nanometric liposome based gene delivery formulations. Arch. Pharm. Res. 30, 1027–1040 (2007).
Suleymanoglu, E. Phospholipid-nucleic acid recognition: developing an immobilized liposome chromatography for DNA separation and analysis. PDA J. Pharm. Sci. Technol. 60, 232–239 (2006).
Gromelski, S. & Brezesinski, G. DNA condensation and interaction with zwitterionic phospholipids mediated by divalent cations. Langmuir 22, 6293–6301 (2006).
Kim, S. I. et al. Systemic and specific delivery of small interfering RNAs to the liver mediated by apolipoprotein A-I. Mol. Ther. 15, 1145–1152 (2007).
McManus, J. J., Radler, J. O. & Dawson, K. A. Does calcium turn a zwitterionic lipid cationic? J. Phys. Chem. B 107, 9869–9875 (2003).
Mengistu, D. H., Bohinc, K. & May, S. Binding of DNA to zwitterionic lipid layers mediated by divalent cations. J. Phys. Chem. B 113, 12277–12282 (2009).
Thery, C., Amigorena, S., Raposo, G. & Clayton, A. Curr. Protoc. Cell Biol. Chapter 3, 22 (John Wiley & Sons, 2006) Unit 3.
Lima, E. S. & Maranhao, R. C. Rapid, simple laser-light-scattering method for HDL particle sizing in whole plasma. Clin. Chem. 50, 1086–1088 (2004).
Simpson, R. J., Lim, J. W., Moritz, R. L. & Mathivanan, S. Exosomes: proteomic insights and diagnostic potential. Expert Rev. Proteomics 6, 267–283 (2009).
Mathivanan, S. & Simpson, R. J. ExoCarta: a compendium of exosomal proteins and RNA. Proteomics 9, 4997–5000 (2009).
Conde-Vancells, J. et al. Characterization and comprehensive proteome profiling of exosomes secreted by hepatocytes. J. Proteome Res. 7, 5157–5166 (2008).
Lim, L. P., Glasner, M. E., Yekta, S., Burge, C. B. & Bartel, D.P. Vertebrate microRNA genes. Science 299, 1540 (2003).
Chen, C. Z., Li, L., Lodish, H. F. & Bartel, D. P. MicroRNAs modulate hematopoietic lineage differentiation. Science 303, 83–86 (2004).
Rader, D. J., Cohen, J. & Hobbs, H. H. Monogenic hypercholesterolemia: New insights in pathogenesis and treatment. J. Clin. Invest. 111, 1795–1803 (2003).
Lund-Katz, S. & Phillips, M. C. High density lipoprotein structure-function and role in reverse cholesterol transport. Subcell. Biochem. 51, 183–227 (2010).
Kosaka, N. et al. Secretory mechanisms and intercellular transfer of microRNAs in living cells. J. Biol. Chem. 285, 17442–17452 (2010).
Sun, G., Li, H. & Rossi, J. J. Sequence context outside the target region influences the effectiveness of miR-223 target sites in the RhoB 3′ UTR. Nucleic Acids Res. 38, 239–252 (2010).
Cui, X. D. et al. EFNA1 ligand and its receptor EphA2: potential biomarkers for hepatocellular carcinoma. Int. J. Cancer 126, 940–949 (2010).
Feinberg, E. H. & Hunter, C. P. Transport of dsRNA into cells by the transmembrane protein SID-1. Science 301, 1545–1547 (2003).
Wolfrum, C. et al. Mechanisms and optimization of in vivo delivery of lipophilic siRNAs. Nat. Biotechnol. 25, 1149–1157 (2007).
Lewis, B. P., Burge, C. B. & Bartel, D. P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120, 15–20 (2005).
Friedman, R. C., Farh, K. K., Burge, C. B. & Bartel, D. P. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 19, 92–105 (2009).
Podrez, E. A. Antioxidant properties of high density lipoprotein and atherosclerosis. Clin. Exp. Pharmacol. Physiol. 37, 719–725 (2010).
Heinecke, J. W. The HDL proteome: a marker–and perhaps mediator–of coronary artery disease. J. Lipid Res. 50 (Suppl), S167–171 (2009).
Rothblat, G. H. & Phillips, M. C. High-density lipoprotein heterogeneity and function in reverse cholesterol transport. Curr. Opin. Lipidol. 21, 229–238 (2010).
Lu, D. & Rhodes, D. G. Binding of phosphorothioate oligonucleotides to zwitterionic liposomes. Biochim. Biophys. Acta 1563, 45–52 (2002).
Qiu, X. et al. Crystal structure of cholesteryl ester transfer protein reveals a long tunnel and four bound lipid molecules. Nat. Struct. Mol. Biol. 14, 106–113 (2007).
Trajkovic, K. et al. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 319, 1244–1247 (2008).
Ferracin, M., Veronese, A. & Negrini, M. Micromarkers: miRNAs in cancer diagnosis and prognosis. Expert Rev. Mol. Diagn. 10, 297–308 (2010).
Wang, G. K. et al. Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur. Heart J. 31, 659–666 (2010).
Wang, J. F. et al. Serum miR-146a and miR-223 as potential new biomarkers for sepsis. Biochem. Biophys. Res. Commun. 394, 184–188 (2010).
Heneghan, H. M., Miller, N., Lowery, A. J., Sweeney, K. J. & Kerin, M. J. MicroRNAs as novel biomarkers for breast cancer. J. Oncol. 2009, 950201 (2009).
Gilad, S. et al. Serum microRNAs are promising novel biomarkers. PLoS One 3, e3148 (2008).
MacArthur, J. M. et al. Liver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins independently of LDL receptor family members. J. Clin. Invest. 117, 153–164 (2007).
Ramakrishnan, S. N., Lau, P., Burke, L. J. & Muscat, G. E. Rev-erbbeta regulates the expression of genes involved in lipid absorption in skeletal muscle cells: evidence for cross-talk between orphan nuclear receptors and myokines. J. Biol. Chem. 280, 8651–8659 (2005).
Yao, Y. et al. High-density lipoproteins affect endothelial BMP-signaling by modulating expression of the activin-like kinase receptor 1 and 2. Arterioscler. Thromb. Vasc. Biol. 28, 2266–2274 (2008).
Moreno, P. R., Purushothaman, K. R., Sirol, M., Levy, A. P. & Fuster, V. Neovascularization in human atherosclerosis. Circulation 113, 2245–2252 (2006).
Lee, H. et al. Hepatic siRNA delivery using recombinant human apolipoprotein A-I in mice. Biochem. Biophys. Res. Commun. 378, 192–196 (2009).
Fukao, T. et al. An evolutionarily conserved mechanism for microRNA-223 expression revealed by microRNA gene profiling. Cell 129, 617–631 (2007).
Gentner, B. et al. Stable knockdown of microRNA in vivo by lentiviral vectors. Nat. Methods 6, 63–66 (2009).
Eyholzer, M. et al. Complexity of miR-223 regulation by CEBPA in human AML. Leuk. Res. 34, 672–676 (2010).
Fazi, F. et al. A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPα regulates human granulopoiesis. Cell 123, 819–831 (2005).
Pulikkan, J. A. et al. Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia. Blood 115, 1768–1778 (2010).
Lu, H., Buchan, R. J. & Cook, S. A. MicroRNA-223 regulates Glut4 expression and cardiomyocyte glucose metabolism. Cardiovasc. Res. 86, 410–420 (2010).
Yu, C. H., Xu, C. F. & Li, Y. M. Association of MicroRNA-223 expression with hepatic ischemia/reperfusion injury in mice. Dig. Dis. Sci. 54, 2362–2366 (2009).
Sugatani, T. & Hruska, K. A. MicroRNA-223 is a key factor in osteoclast differentiation. J. Cell Biochem. 101, 996–999 (2007).
Iida, H. et al. Ephrin-A1 expression contributes to the malignant characteristics of {α}-fetoprotein producing hepatocellular carcinoma. Gut 54, 843–851 (2005).
Huang, L. et al. Immunoaffinity separation of plasma proteins by IgY microbeads: meeting the needs of proteomic sample preparation and analysis. Proteomics 5, 3314–3328 (2005).
Nieuwland, R. et al. Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood 95, 930–935 (2000).
Matz, C. E. & Jonas, A. Micellar complexes of human apolipoprotein A-I with phosphatidylcholines and cholesterol prepared from cholate-lipid dispersions. J. Biol. Chem. 257, 4535–4540 (1982).
Griffiths-Jones, S., Saini, H. K., van Dongen, S. & Enright, A. J. miRBase: tools for microRNA genomics. Nucleic Acids Res. 36, D154–158 (2008).
Cline, M. S. et al. Integration of biological networks and gene expression data using Cytoscape. Nat. Protoc. 2, 2366–2382 (2007).
Li, C. & Wong, W. H. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc. Natl Acad. Sci. USA 98, 31–36 (2001).
Acknowledgements
This study was helped by the NHLBI Electron Microscopy Core, Genomics Core and Proteomics Core Facilities. Special thanks are extended to P. Sethupathy, PhD, for target prediction and discussion, M. Sampson for her work on patient lipid profiles and A. Loncarich for statistical analysis. This research was supported in total by the Intramural Research Program of the NIH, NHLBI DIR.
Author information
Authors and Affiliations
Contributions
K.C.V., B.T.P. and A.T.R. designed the research plan and study. K.C.V., B.T.P. and B.M.S. carried out all experiments. R.D.S. provided human samples. K.C.V. and A.T.R. drafted and edited the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Information
Supplementary Information (PDF 620 kb)
Supplementary Information
Supplementary Information (PDF 1113 kb)
Rights and permissions
About this article
Cite this article
Vickers, K., Palmisano, B., Shoucri, B. et al. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol 13, 423–433 (2011). https://doi.org/10.1038/ncb2210
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncb2210
This article is cited by
-
The potential of microRNAs in cancer diagnostic and therapeutic strategies: a narrative review
The Journal of Basic and Applied Zoology (2024)
-
CD204-positive M2-like tumor-associated macrophages increase migration of gastric cancer cells by upregulating miR-210 to reduce NTN4 expression
Cancer Immunology, Immunotherapy (2024)
-
MicroRNAs and Cardiovascular Disease Risk
Current Cardiology Reports (2024)
-
From diagnosis to resistance: a symphony of miRNAs in pheochromocytoma progression and treatment response
Naunyn-Schmiedeberg's Archives of Pharmacology (2024)
-
Proteomic and functional analysis of HDL subclasses in humans and rats: a proof-of-concept study
Lipids in Health and Disease (2023)